9:10 - 9:15 Moderator introduction (Nirmal Kaur, M.D.)
9:15 - 9:35 COVID 19 Infection and Vaccination in Patients with IBD (Jason Schairer, M.D.)
COVID-19 has raised a number of questions for in the care of IBD, specifically regarding safety of medications and vaccinations. Dr. Schairer will provide a data-driven look at the recommendations used to keep our patients with IBD safe during the pandemic.
9:35 - 9:55 IBD Surgery and Complications (Edwin Itenberg, DO)
The goal of this presentation is to educate attendees about anorectal disease in Crohn's patients, specifically anal fistulas. Dr. Itenberg will describe current treatment options and research, and future therapies.
9:55 - 10:15 Management of Joint Pain in Patients with IBD Rachel Adler, CMP
Assessing joint pain in IBD patients can be challenging, as the root cause could be disease-related or drug-related. In this lecture, Ms. Adler, who has years of experience in Rheumatology, will review a practical approach to assessing, temporizing, and ultimately treating joint pain in IBD.
Please visit our virtual exhibit hall
10:35 - 10:40 Moderator Introduction (Reena Salgia, MD)
10:40 - 11:00 Management of Variceal Bleeding in 2021 (Kimberly Brown, MD)
Esophageal and gastric varices are a common complication of portal hypertension in patients with liver disease. We will review current guidelines for both diagnosis and management and provide guidance for clinicians to incorporate new tools including Fibroscan and BRTO in managing their patients.
11:00 - 11:20 Updates in NASH: The skinny on fatty liver disease (Deepak Venkat, MD)
We will address best practices in the care of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Discussion will focus on current understanding of epidemiology, diagnostic testing, management and long-term follow up care with commentary on the most up-to-date modalities of care.
11:20 - 11:40 The Shifting Paradigm: Early Liver Transplantation for Acute Alcoholic Hepatitis (Syed-Mohammed Jafri, MD)
The field of hepatology has seen a dramatic shift in the paradigm of alcoholic hepatitis including earlier transplantation for a select group of patients. We will discuss the medical and surgical management of alcoholic hepatitis and which patients are most appropriate for transplant evaluation and listing.
Please visit our virtual exhibit hall
1:00 - 1:05 Moderator Introduction (Brian Ginnebaugh, M.D.)
1:05 - 1:25 Medical Approach to the Treatment of Refractory Gastroparesis (Eva Alsheik, M.D.)
1:25 - 1:45 Surgical Options for Refractory Gastroparesis (Kellie McFarlin, M.D.)
1:45 - 2:05 GPOEM and the Role of Endoscopy for Refractory Gastroparesis (Cyrus Piraka, M.D.)
In this collaborative series of three lectures, we seek to dive deep into the medical, endoscopic, and surgical therapies for refractory gastroparesis. We will focus on the importance of a multidisciplinary approach to better individualize therapy for this challenging patient population.
Please visit our virtual exhibit hall
2:25 - 2:30 Moderator Introduction (Eva Alsheik, M.D.)
2:30 - 2:50 The LAMS Revolution (Tobias Zuchelli, M.D.)
Lumen apposing metal stents (LAMS) have transformed the field of therapeutic endoscopy. This talk will review current and future applications for LAMS, including the use in surgically altered anatomy.
2:50 - 3:10 Endoscopic Approach to Cancer (Sumit Singla, M.D.)
Evolving technologies within the field of therapeutic endoscopy are increasingly allowing practitioners to deliver treatment for GI tract malignancies. In this session, we will describe how cholangioscopy can aid in precise staging and palliation of patients with cholangiocarcinoma, and discuss how this paradigm shift towards “GI Oncology” will benefit our patients.
3:10 - 3:30 Chicago Classification v 4.0: Updates in Esophageal Motility Testing (Brian Ginnebaugh, M.D.)
Over the years, the Chicago Classification has been instrumenta in diagnosing and understanding both esophageal motility and esophageal outlet disorders. We will review the newest updates to the guidelines and why these changes are clinically relevant to our patients.
2020 has been a year to remember… Even though we would all like to forget! How have you adapted during a crisis? How have you had to change? Sit in on this session and learn about tools that can help members.
After two full days of learning, you might be wondering what to do with all this information. Sit in and hear first-hand from subject-matter experts have to say on the topic. The Learning Core series wraps up with its Best Practices where it shows you how apply this knowledge to team.
